James Licht
Cardiovascular Disease · Los Alamitos, CANPI 1841296506
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Amgen at 24.1% of the total. That places this record below the midpoint for cardiovascular disease clinicians in CA, where the typical reported total is $2,142.
Across 70 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$306
- United Therapeutics Corporation$139
- Novartis$122
- Johnson & Johnson$117
- Gilead$90
- Sanofi-aventis U.S. LLC$82
- plus $415 from 15 others
What the payments were for
- Food & beverage$1,270100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 15 | $306 |
| United Therapeutics Corporation | 6 | $139 |
| Novartis | 8 | $122 |
| Johnson & Johnson | 7 | $117 |
| Gilead | 5 | $90 |
| Sanofi-aventis U.S. LLC | 4 | $82 |
| Kowa Pharmaceuticals America, Inc. | 5 | $81 |
| Pfizer | 3 | $57 |
| Boehringer Ingelheim | 3 | $44 |
| AstraZeneca | 2 | $36 |
| Boston Scientific | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $21 |
| Merck | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $17 |
| Lemaitre Vascular, Inc. | 1 | $15 |
| Portola Pharmaceuticals, LLC | 1 | $14 |
| AbbVie | 1 | $12 |
| Medtronic | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$1,270 in reported general payments places this provider in the 40th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Los Alamitos
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
- Wilber SuStanford$1.1M
- Thomas SmithSacramento$942K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.